000 | 01998 a2200553 4500 | ||
---|---|---|---|
005 | 20250514221841.0 | ||
264 | 0 | _c20050628 | |
008 | 200506s 0 0 eng d | ||
022 | _a1535-7163 | ||
024 | 7 |
_a10.1158/1535-7163.MCT-04-0232 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aKudo, Yasusei | |
245 | 0 | 0 |
_aSmall interfering RNA targeting of S phase kinase-interacting protein 2 inhibits cell growth of oral cancer cells by inhibiting p27 degradation. _h[electronic resource] |
260 |
_bMolecular cancer therapeutics _cMar 2005 |
||
300 |
_a471-6 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntimetabolites, Antineoplastic _xpharmacology |
650 | 0 | 4 | _aBlotting, Western |
650 | 0 | 4 |
_aBromodeoxyuridine _xpharmacology |
650 | 0 | 4 |
_aCarcinoma, Squamous Cell _xmetabolism |
650 | 0 | 4 |
_aCell Cycle Proteins _xantagonists & inhibitors |
650 | 0 | 4 | _aCell Line, Tumor |
650 | 0 | 4 | _aCell Proliferation |
650 | 0 | 4 | _aCyclin-Dependent Kinase Inhibitor p27 |
650 | 0 | 4 | _aDown-Regulation |
650 | 0 | 4 | _aGene Silencing |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aIn Situ Nick-End Labeling |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Nude |
650 | 0 | 4 | _aModels, Genetic |
650 | 0 | 4 |
_aMouth Neoplasms _xdrug therapy |
650 | 0 | 4 |
_aPlasmids _xmetabolism |
650 | 0 | 4 | _aProteasome Inhibitors |
650 | 0 | 4 | _aRNA Interference |
650 | 0 | 4 |
_aRNA, Small Interfering _xmetabolism |
650 | 0 | 4 |
_aS-Phase Kinase-Associated Proteins _xgenetics |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 | _aTransfection |
650 | 0 | 4 |
_aTumor Suppressor Proteins _xantagonists & inhibitors |
700 | 1 | _aKitajima, Shojiro | |
700 | 1 | _aOgawa, Ikuko | |
700 | 1 | _aKitagawa, Masae | |
700 | 1 | _aMiyauchi, Mutsumi | |
700 | 1 | _aTakata, Takashi | |
773 | 0 |
_tMolecular cancer therapeutics _gvol. 4 _gno. 3 _gp. 471-6 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1158/1535-7163.MCT-04-0232 _zAvailable from publisher's website |
999 |
_c15440270 _d15440270 |